IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

An2 Thereapeutics Inc

Q1 2026 vs Q2 2026

Comparing institutional holders between quarters

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Aldebaran Capital, LLC
DECREASED
Shares367,435 from 371,770
Change-4,335 (-1%)
Value$1.8M (+$506.9K)
Filed 2026-08-14
Status
Aldebaran Capital, LLC
DECREASED367,435371,770-4,335-1%$1.3M$1.8M+$506.9K2026-08-14
Showing 1 of 1 institutions